Aztreonam for inhalation solution (Cayston) for cystic fibrosis.
D000280:Administration, Inhalation; D000818:Animals; D001398:Aztreonam / Q000008:administration & dosage* / Q000494:pharmacology / Q000627:therapeutic use; D017326:Clinical Trials, Phase III as Topic / Q000379:methods; D003550:Cystic Fibrosis / Q000188:drug therapy* / Q000382:microbiology; D006801:Humans; D019999:Pharmaceutical Solutions / Q000008:administration & dosage / Q000494:pharmacology / Q000627:therapeutic use; D011550:Pseudomonas aeruginosa / Q000187:drug effects
D019999:Pharmaceutical Solutions; D001398:Aztreonam